Vous n'êtes pas connecté
The FDA bestows a Fast Track designation to Sanofi's two combination vaccine candidates to prevent influenza and COVID-19 infections.
The contentious Fast-track Approvals Bill is now law - but it hit a few speed bumps on the way.